Outlook Therapeutics Inc. (OTLK)
NASDAQ · Healthcare
Outlook Therapeutics Inc. Shareholder Equity 2015–2025
Outlook Therapeutics Inc. annual shareholder equity history from 2015 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Outlook Therapeutics Inc. shareholder equity as of September 30, 2025: -32.2M, a 99.56% increase year-over-year.
- Outlook Therapeutics Inc. shareholder equity for 2025 were -32.2M, a 99.56% increase from 2019.
- Outlook Therapeutics Inc. shareholder equity for 2019 were -16.1M, a 36.86% decrease from 2018.
- Outlook Therapeutics Inc. shareholder equity for 2018 were -25.5M, a 24.09% decrease from 2017.
- Outlook Therapeutics Inc. shareholder equity for 2017 were -33.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Outlook Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-32 |
| 2019 | $-16 |
| 2018 | $-26 |
| 2017 | $-34 |
| 2016 | $-5 |
| 2015 | $-54 |
Outlook Therapeutics Inc. Shareholder Equity — FAQ
Outlook Therapeutics Inc. (OTLK) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OTLK's shareholder equity history?
The chart and table above show Outlook Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.